What’s next for pharmaceutical companies in an increasingly complex industry? Peter Sheppard, Europe life sciences leader, Genpact asks.
As I look back at the last decade, I’m struck by how the pace of change in the pharmaceutical industry has accelerated, but also, looking forward by how the industry’s winners will be defined by an ability to rapidly re-allocate resources to take advantage of new opportunities.